Long-Term Assessment of Topiramate for Epilepsy: An Open-Label, Single-Arm, Multicentre, Prospective Study in a Naturalistic Setting

By Hufnagel Andreas  

Clinical Drug Investigation, Vol. 31, Iss. 11, 2011-11 ,pp. : 779-790

Adis International

Access to resources Recommend Favorite

Use of Recombinant Human Parathyroid Hormone(1-84) in Patients with Postmenopausal Osteoporosis: A Prospective, Open-Label, Single-Arm, Multicentre, Observational Cohort Study of the Effects of Treatment on Quality of Life and Pain - the PROPOSE Study

By Möricke Rüdiger  

Clinical Drug Investigation, Vol. 31, Iss. 2, 2011-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Tolerability and Safety of Topiramate in Chinese Patients with Epilepsy: An Open-Label, Long-Term, Prospective Study

By Lu Yang  

Clinical Drug Investigation, Vol. 27, Iss. 10, 2007-01 ,pp. : 683-690

Adis International

Access to resources Recommend Favorite

Visual Field Loss in Patients with Refractory Partial Epilepsy Treated with Vigabatrin: Final Results from an Open-Label, Observational, Multicentre Study

By Wild John M.  

CNS Drugs, Vol. 23, Iss. 11, 2009-11 ,pp. : 965-982

Adis International

Access to resources Recommend Favorite

Oral L-Ornithine-L-Aspartate Improves Health-Related Quality of Life in Cirrhotic Patients with Hepatic Encephalopathy: An Open-Label, Prospective, Multicentre Observational Study

By Ong Janus P.   Oehler Gerd  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 213-220

Adis International

Access to resources Recommend Favorite